Cargando…
The Epigenetics of Migraine
Migraine is a complex neurological disorder and a major cause of disability. A wide range of different drug classes such as triptans, antidepressants, anticonvulsants, analgesics, and beta-blockers are used in acute and preventive migraine therapy. Despite a considerable progress in the development...
Autores principales: | Zobdeh, Farzin, Eremenko, Ivan I., Akan, Mikail A., Tarasov, Vadim V., Chubarev, Vladimir N., Schiöth, Helgi B., Mwinyi, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252316/ https://www.ncbi.nlm.nih.gov/pubmed/37298078 http://dx.doi.org/10.3390/ijms24119127 |
Ejemplares similares
-
Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review
por: Zobdeh, Farzin, et al.
Publicado: (2022) -
Pharmacogenetics in Primary Headache Disorders
por: Belyaeva, Irina I., et al.
Publicado: (2022) -
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis
por: Affatato, Oreste, et al.
Publicado: (2021) -
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
por: Namiot, Eugenia D., et al.
Publicado: (2023) -
Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials
por: Namiot, Eugenia D., et al.
Publicado: (2022)